티앤엘

340570KOSDAQ의료용품 및 기타 의약 관련제품 제조업

64.5 / 100

Reference Date: 2026-04-13

Financial Score29.0 / 40

News Sentiment17.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Slightly up 1.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

T&L is a high-performance material specialist company producing and selling wound dressings (hydrocolloid, polyurethane foam), microneedles, and orthopedic fixation materials. Its flagship product, wound dressings, protect wounds and prevent fluid loss, with plans to expand into dermocosmetics and pharmaceutical markets using its material technology.

Number of Employees

237people

Average Salary

76.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.02Industry Average 19.896.5Point

Lower than industry avg (good)

PBR

2.08Industry Average 1.622.5Point

Higher than industry avg (caution)

ROE

20.44Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

0.36Industry Average 8.888.0Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲22.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲33.0% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 24.9% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 70

Neutral
[거버넌스워치] ‘여드름 패치’ 티앤엘 장남, 임원 달자 이사회 직행....
티앤엘은 창업자 최윤소 대표의 맏아들 최현준 상무가 임원 승진과 주식 증여에 이어 이사회 멤버로 신규 선임될 예정으로, 2대 장남 승계가 빠르게 진행되고 있습니다.
Positive
티앤엘, C&D 유통망 확장에 3M ODM까지 '성장 재점화’
티앤엘은 처치앤드와이트(C&D) 유통망 확대와 3M 제조자개발생산(ODM) 공급 논의가 맞물리며 중장기 성장 동력이 다시 주목받고 있습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 51,600Won52-week high 74,20052-week low 43,550

1-month return3.0Point

1m 1.38% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-04-09
Neutral기업가치제고계획(자율공시)2026-03-27
Neutral정기주주총회결과2026-03-26
Neutral감사보고서제출2026-03-18
Neutral사업보고서 (2025.12)2026-03-18